Urinary proteome profile predictive of disease activity in rheumatoid arthritis

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 5206-5217

  Kang, Min Jueng ^a   Park, Yune Jung ^b   You, Sungyong ^c   Yoo, Seung Ah ^d   Choi, Susanna ^d   Kim, Dong Ho ^d   Cho, Chul Soo ^d,e   Yi, Eugene C ^a   Hwang, Daehee ^c,f,h   Kim, Wan Uk ^d,g  

^a Seoul National University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e The Catholic University of Korea   (South Korea)

^f Institute for Basic Science   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h Institute for Basic Science   (South Korea)

Author keywords

biomarkers; LC MS MS analysis; rheumatoid arthritis; soluble CD14; urine

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; PROTEOME; BIOLOGICAL MARKER;

ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PREDICTIVE VALUE; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RHEUMATOID ARTHRITIS; TANDEM MASS SPECTROMETRY; URINALYSIS; ARTHRITIS, RHEUMATOID; CASE CONTROL STUDY; COHORT ANALYSIS; PHYSIOLOGY; PROCEDURES; PROTEINURIA; PROTEOMICS; REPRODUCIBILITY; SYNOVIAL FLUID; SYSTEMIC LUPUS ERYTHEMATOSUS; URINE;

ANTIGENS, CD14; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OSTEOARTHRITIS; PREDICTIVE VALUE OF TESTS; PROTEINURIA; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SYNOVIAL FLUID; TANDEM MASS SPECTROMETRY;

EID: 84908884333     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500467d     Document Type: Article

References (54)

1. Firestein, G. S. Evolving concepts of rheumatoid arthritis Nature 2003, 423 (6937) 356-361
2. Nell, V.; Machold, K. P.; Stamm, T. A.; Eberl, G.; Heinzl, H.; Uffmann, M.; Smolen, J. S.; Steiner, G. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis Ann. Rheum. Dis. 2005, 64 (12) 1731-1736
3. Smolen, J. S.; Aletaha, D.; Bijlsma, J. W.; Breedveld, F. C.; Boumpas, D.; Burmester, G.; Combe, B.; Cutolo, M.; de Wit, M.; Dougados, M. Treating rheumatoid arthritis to target: recommendations of an international task force Ann. Rheum. Dis. 2010, 69 (4) 631-637
4. Kushner, I. C-reactive protein in rheumatology Arthritis Rheum. 1991, 34 (8) 1065-1068
5. Carson, D.; Chen, P.; Fox, R.; Kipps, T.; Jirik, F.; Goldfien, R.; Silverman, G.; Radoux, V.; Fong, S. Rheumatoid factor and immune networks Annu. Rev. Immunol. 1987, 5 (1) 109-126
6. Carson, D. A.; Chen, P. P.; Kipps, T. J. New roles for rheumatoid factor J. Clin. Invest. 1991, 87 (2) 379-383
7. Coenen, D.; Verschueren, P.; Westhovens, R.; Bossuyt, X. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis Clin. Chem. 2007, 53 (3) 498-504
8. van Gaalen, F.; Ioan-Facsinay, A.; Huizinga, T. W.; Toes, R. E. The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis J. Immunol. 2005, 175 (9) 5575-5580
9. Greiner, A.; Plischke, H.; Kellner, H.; Gruber, R. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis Ann. N.Y. Acad. Sci. 2005, 1050 (1) 295-303
10. Barratt, J.; Topham, P. Urine proteomics: the present and future of measuring urinary protein components in disease Can. Med. Assoc. J. 2007, 177 (4) 361-368
11. Rovin, B. H.; Song, H.; Birmingham, D. J.; Hebert, L. A.; Yu, C. Y.; Nagaraja, H. N. Urine chemokines as biomarkers of human systemic lupus erythematosus activity J. Am. Soc. Nephrol. 2005, 16 (2) 467-473
12. Zürbig, P.; Jerums, G.; Hovind, P.; MacIsaac, R.; Mischak, H.; Nielsen, S. E.; Panagiotopoulos, S.; Persson, F.; Rossing, P. Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy Diabetes 2012, 61 (12) 3304-3313
13. Prete, M.; Racanelli, V.; Digiglio, L.; Vacca, A.; Dammacco, F.; Perosa, F. Extra-articular manifestations of rheumatoid arthritis: An update Autoimmun. Rev. 2011, 11 (2) 123-131
14. Arnett, F. C.; Edworthy, S. M.; Bloch, D. A.; Mcshane, D. J.; Fries, J. F.; Cooper, N. S.; Healey, L. A.; Kaplan, S. R.; Liang, M. H.; Luthra, H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum. 1988, 31 (3) 315-324
15. Prevoo, M.; Vant Hof, M.; Kuper, H.; Van Leeuwen, M.; Van de Putte, L.; Van Riel, P. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum. 1995, 38 (1) 44-48
16. Van der Heijde, D. How to read radiographs according to the Sharp/van der Heijde method J. Rheumatol. 1999, 26 (3) 743-745
17. Adachi, J.; Kumar, C.; Zhang, Y.; Olsen, J. V.; Mann, M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins Genome Biol. 2006, 7 (9) R80
18. Su, L.; Cao, L.; Zhou, R.; Jiang, Z.; Xiao, K.; Kong, W.; Wang, H.; Deng, J.; Wen, B.; Tan, F. Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS PLoS One 2013, 8 (1) e54237
19. Zoidakis, J.; Makridakis, M.; Zerefos, P. G.; Bitsika, V.; Esteban, S.; Frantzi, M.; Stravodimos, K.; Anagnou, N. P.; Roubelakis, M. G.; Sanchez-Carbayo, M. Profilin 1 is a potential biomarker for bladder cancer aggressiveness Mol. Cell. Proteomics 2012, 11 (4) M111. 009449
20. Afkarian, M.; Bhasin, M.; Dillon, S. T.; Guerrero, M. C.; Nelson, R. G.; Knowler, W. C.; Thadhani, R.; Libermann, T. A. Optimizing a proteomics platform for urine biomarker discovery Mol. Cell. Proteomics 2010, 9 (10) 2195-2204
21. Rosenfeld, J.; Capdevielle, J.; Guillemot, J. C.; Ferrara, P. In-gel digestion of proteins for internal sequence analysis after one-or two-dimensional gel electrophoresis Anal. Biochem. 1992, 203 (1) 173-179
22. Yi, E. C.; Lee, H.; Aebersold, R.; Goodlett, D. R. A microcapillary trap cartridge microcapillary high performance liquid chromatography electrospray ionization emitter device capable of peptide tandem mass spectrometry at the attomole level on an ion trap mass spectrometer with automated routine operation Rapid Commun. Mass Spectrom. 2003, 17 (18) 2093-2098
23. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74 (20) 5383-5392
24. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75 (17) 4646-4658
25. Braisted, J. C.; Kuntumalla, S.; Vogel, C.; Marcotte, E. M.; Rodrigues, A. R.; Wang, R.; Huang, S. T.; Ferlanti, E. S.; Saeed, A. I.; Fleischmann, R. D. The APEX Quantitative Proteomics Tool: generating protein quantitation estimates from LC-MS/MS proteomics results BMC Bioinf. 2008, 9 (1) 529
26. Bolstad, B. M.; Irizarry, R. A.; Åstrand, M.; Speed, T. P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Bioinformatics 2003, 19 (2) 185-193
27. Chae, S.; Ahn, B. Y.; Byun, K.; Cho, Y. M.; Yu, M.; Lee, B.; Hwang, D.; Park, K. S. A systems approach for effective decoding of mitochondrial retrograde signaling pathways Sci. Signaling 2013, 6, 264-275
28. Hwang, D.; Rust, A. G.; Ramsey, S.; Smith, J. J.; Leslie, D. M.; Weston, A. D.; De Atauri, P.; Aitchison, J. D.; Hood, L.; Siegel, A. F. A data integration methodology for systems biology Proc. Natl. Acad. Sci. U. S. A. 2005, 102 (48) 17296-17301
29. Storey, J. D.; Tibshirani, R. Statistical significance for genomewide studies Proc. Natl. Acad. Sci. U. S. A. 2003, 100 (16) 9440-9445
30. Da Wei Huang, B. T. S.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 2008, 4 (1) 44-57
31. Edgar, R.; Domrachev, M.; Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Nucleic Acids Res. 2002, 30 (1) 207-210
32. Farrah, T.; Deutsch, E. W.; Omenn, G. S.; Campbell, D. S.; Sun, Z.; Bletz, J. A.; Mallick, P.; Katz, J. E.; Malmström, J.; Ossola, R. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas Mol. Cell. Proteomics 2011, 10 (9) M110.006353
33. Vogel, C.; Marcotte, E. M. Calculating absolute and relative protein abundance from mass spectrometry-based protein expression data Nat. Protoc. 2008, 3 (9) 1444-1451
34. Alvord, G.; Roayaei, J.; Stephens, R.; Baseler, M. W.; Lane, H. C.; Lempicki, R. A. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists Genome Biol. 2007, 8, R183
35. Huber, R.; Hummert, C.; Gausmann, U.; Pohlers, D.; Koczan, D.; Guthke, R.; Kinne, R. W. Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane Arthritis Res. Ther. 2008, 10 (4) R98
36. Ungethuem, U.; Haeupl, T.; Witt, H.; Koczan, D.; Krenn, V.; Huber, H.; von Helversen, T. M.; Drungowski, M.; Seyfert, C.; Zacher, J. Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis Physiol. Genomics. 2010, 42 (4) 267-282
37. Teixeira, V. H.; Olaso, R.; Martin-Magniette, M.-L.; Lasbleiz, S.; Jacq, L.; Oliveira, C. R.; Hilliquin, P.; Gut, I.; Cornelis, F.; Petit-Teixeira, E. Transcriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patients PLoS One 2009, 4 (8) e6803
38. Bansard, C.; Lequerré, T.; Derambure, C.; Vittecoq, O.; Hiron, M.; Daragon, A.; Pouplin, S.; Daveau, M.; Boyer, O.; Tron, F. Gene profiling predicts rheumatoid arthritis responsiveness to IL-1Ra (anakinra) Rheumatology 2011, 50 (2) 283-292
39. You, S.; Cho, C.-S.; Lee, I.; Hood, L.; Hwang, D.; Kim, W.-U. A systems approach to rheumatoid arthritis PLoS One 2012, 7 (12) e51508
40. Bas, S.; Gauthier, B. R.; Spenato, U.; Stingelin, S.; Gabay, C. CD14 is an acute-phase protein J. Immunol. 2004, 172 (7) 4470-4479
41. Yu, S.; Nakashima, N.; Xu, B.; Matsuda, T.; Izumihara, A.; Sunahara, N.; Nakamura, T.; Tsukano, M.; Matsuyama, T. Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts Rheumatol. Int. 1998, 17 (6) 237-243
42. Juling, Z.; Xiaosen, Q.; Xiangqin, C.; Trenton, R. S.; Lesley, E. S.; Martin, R. J.; Lisa, M. G.; Arlene, B. C.; Michal, M. Renal CD14 expression correlates with the progression of cystic kidney disease Kidney Int. 2010, 78 (6) 550-560
43. Torffvit, O.; Agardh, C. D.; Thulin, T. A study of Tamm-Horsfall protein excretion in hypertensive patients and type 1 diabetic patients Scand. J. Urol. Nephrol. 1999, 33 (3) 187-191
44. Yildirim, K.; Karatay, S.; Melikoglu, M. A.; Gureser, G.; Ugur, M.; Senel, K. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis Ann. Clin. Lab. Sci. 2004, 34 (4) 423-426
45. Dixon, J.; Bird, H.; Sitton, N.; Pickup, M.; Wright, V. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis Scand. J. Rheumatol. 1984, 13 (1) 39-44
46. Otterness, I. G. In The value of C-reactive protein measurement in rheumatoid arthritis Semin. Arthritis Rheum. 1994, 24 (2) 91-104
47. Zhang, Q.-H.; Li, J.-C.; Dong, N.; Tang, L.-M.; Zhu, X.-M.; Sheng, Z.-Y.; Yao, Y.-M. Burn injury induces gelsolin expression and cleavage in the brain of mice Neuroscience 2012, 3 (228) 60-72
48. Cylwik, B.; Chrostek, L.; Gindzienska-Sieskiewicz, E.; Sierakowski, S.; Szmitkowski, M. Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis Adv. Med. Sci. 2010, 55 (1) 80-85
49. Nakamura, T.; Board, P. G.; Matsushita, K.; Tanaka, H.; Matsuyama, T.; Matsuda, T. α 1 Acid glycoprotein expression in human leukocytes: Possible correlation between α 1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis Inflammation 1993, 17 (1) 33-45
50. Mikuls, T. R.; LeVAN, T. D.; Sayles, H.; Yu, F.; Caplan, L.; Cannon, G. W.; Kerr, G. S.; Reimold, A. M.; Johnson, D. S.; Thiele, G. M. Soluble CD14 and CD14 polymorphisms in rheumatoid arthritis J. Rheumatol. 2011, 38 (12) 2509-2516
51. Horneff, G.; Sack, U.; Kalden, J.; Emmrich, F.; Burmester, G. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis Clin. Exp. Immunol. 1993, 91 (2) 207-213
52. Boers, M.; Dijkmans, B. A. C.; Breedveld, F. C.; Camps, J. A. J.; Chang, P. C.; Brummelen, P. V.; Pauwels, E. K. J.; Cats, A. Subclinical renal dysfunction in rheumatoid arthritis Arthritis Rheum. 1990, 33 (1) 95-101
53. Pedersen, L. M.; Nordin, H.; Svensson, B.; Bliddal, H. Microalbuminuria in patients with rheumatoid arthritis Ann. Rheum. Dis. 1995, 54 (3) 189-192
54. Katz, M. H. Multivariable Analysis: A Practical Guide for Clinicians; Cambridge University Press: New York, 2006.